Circulating tumor cells may be alternative for biomarker assessment

Harris, Jason; Southall, Jennifer
October 2010
Hem/Onc Today;10/25/2010, Vol. 11 Issue 20, p20
The article discusses research being done on the use of circulating tumor cells as a noninvasive alternative for biomarker assessment, which references a study by Siminder Kaur and colleagues presented at the American Association for Cancer Research (AACR) International Conference in Denver, Colorado from September 27-30, 2010.


Related Articles

  • New Breast-to-Brain Metastasis Signature. Breindl, Anette // BioWorld Today;4/15/2013, Vol. 24 Issue 71, p9 

    This article discusses a research paper on a set of biomarkers that identify metastasis-prone brain cancer cells, referencing a study published in the April 11, 2013 issue of "Science Tranlational Medicine".

  • A cycle of success: the interdependence of surgery and science. Schneider, M.; Welsch, T.; Kremer, M.; Büchler, M. // Langenbeck's Archives of Surgery;Apr2012, Vol. 397 Issue 4, p493 

    An introduction is presented in which the editor discusses various reports within the issue on topics including genetic and molecular characteristics of cancer cells, resistance of colorectal tumours against chemo and radiation therapy, and suitable biomarkers for oncologic treatment.

  • Robust Automated Tumour Segmentation on Histological and Immunohistochemical Tissue Images. Ching-Wei Wang // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Tissue microarray (TMA) is a high throughput analysis tool to identify new diagnostic and prognostic markers in human cancers. However, standard automated method in tumour detection on both routine histochemical and immunohistochemistry (IHC) images is under developed. This paper presents a...

  • Pinellia pedatisecta agglutinin-based lectin blot analysis distinguishes between glycosylation patterns in various cancer cell lines. NA LI; GUOPING DONG; SHUANGHUI WANG; SHIPING ZHU; YI SHEN; GONGCHU LI // Oncology Letters;2014, Vol. 8 Issue 2, p837 

    The analysis of altered glycosylation patterns may provide biomarkers for various types of cancer. The present study developed a Pinellia pedatisecta agglutinin (PPA)-based lectin blot analysis technique, which was used to analyze the glycosylation patterns in various types of cancer cells....

  • Ultrasensitive detection of DNA and protein markers in cancer cells. Smolina, Irina V.; Broude, Natalia E. // Cancer Biology & Medicine;Sep2015, Vol. 12 Issue 3, p143 

    Cancer cells differ from normal cells in various parameters, and these differences are caused by genomic mutations and consequential altered gene expression. The genetic and functional heterogeneity of tumor cells is a major challenge in cancer research, detection, and effective treatment. As...

  • Clinical biomarkers for hypoxia targeting. Quynh-Thu Le; Don Courter // Cancer & Metastasis Reviews;Sep2008, Vol. 27 Issue 3, p351 

    Abstract  Tumor hypoxia or a reduction of the tissue oxygen tension is a key microenvironmental factor for tumor progression and treatment resistance in solid tumors. Because hypoxic tumor cells have been demonstrated to be more resistant to ionizing radiation, hypoxia has been a focus of...

  • Electrochemical Sandwich Immunoassay for the Ultrasensitive Detection of Human MUC1 Cancer Biomarker. Taleat, Zahra; Cristea, Cecilia; Marrazza, Giovanna; Săndulescu, Robert // International Journal of Electrochemistry;2013, p1 

    A new electrochemical sandwich immunoassay for the ultrasensitive detection of human MUC1 cancer biomarker using protein G-functionalized magnetic beads (MBs) and graphite-based screen-printed electrodes (SPEs) was developed. Magnetic beads were employed as the platforms for the immobilization...

  • Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. Straume, O.; Akslen, L. A. // British Journal of Cancer;10/17/2005, Vol. 93 Issue 8, p933 

    The ID1 protein, an inhibitor of basic helix-loop-helix transcription factors, has been involved in multiple cellular processes including cell cycle regulation, apoptosis, and angiogenesis. To evaluate the importance of ID1 in malignant melanoma, tumour cell expression was examined by...

  • Notch-1 and Notch-4 Biomarker Expression in Triple-Negative Breast Cancer. Speiser, Jodi; Foreman, Kimberly; Drinka, Eva; Godellas, Constantine; Perez, Claudia; Salhadar, Alia; Erşahin, Çağatay; Rajan, Prabha // International Journal of Surgical Pathology;Apr2012, Vol. 20 Issue 2, p137 

    Triple-negative breast cancer (TNBC) demonstrates lack of expression of hormone receptors and human epidermal growth factor receptor. However, there is no targeted therapy for TNBC. The authors analyzed 29 TNBC cases for Notch-1 and Notch-4 biomarker expression and subcellular location, Ki67...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics